Redwire’s stock plummeted over 30% this week due to a drop in revenue and significant net losses. Despite this, the company is developing cutting-edge technologies in satellites, drone surveillance, and biotechnology solutions for space, with over $11 billion potential revenue in the pipeline.

Redwire reported a net loss of $78.9 million in the second quarter of 2025, along with a decrease in revenue to $61.8 million. The company attributes the drop in revenue to delayed contracts, such as the Golden Dome project with a substantial budget from the United States.

While facing challenges, Redwire secured over $90 million in contracts last quarter and aims to win more from the U.S. military. The company is also exploring biotech research in space and missions to the moon and Mars. Despite losses, it has a book-to-bill ratio of 1.47, indicating more orders than fulfilled contracts.

Investing in Redwire may be risky, but with a market cap of $1.3 billion and potential U.S. government spending on space and defense technology, the company’s future looks promising. It remains a high-risk stock but offers exposure to innovative developments in the sector.

Read more at Yahoo Finance: Why Redwire Stock Collapsed 30% This Week